(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AAA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

AAA

ST13

US500000088339647

Class

5, 42, 44

Filing

88339647

Registration

5994205

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

02/25/2025

Trademark type

Combined

Nice classes

5, 42, 44

Filing date

03/14/2019

Registration date

02/25/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/25/2020

Last transaction

02/25/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

5

Owner type

99

Owner location

Basel, CH

Examiner

SINGLETON, RUDY

Law office

L20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a design of three overlapping stylized letters ''A''.

Holders and representatives

Holders

Altavant Sciences GmbH

Representatives

Allison Strickland Ricketts Fross Zelnick Lehrman & Zissu, P.C.

Technical classification

Nice Classes

Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for human use for the treatment of pulmonary arterial hypertensionpulmonary fibrosissarcoidosisrespiratory diseasesdisorders and conditions; biologic preparations for medical and therapeutic purposes for the treatment of pulmonary arterial hypertensionpulmonary fibrosissarcoidosisrespiratory diseasesdisorders and conditions

Class 42

Scientific and technological servicesmedical researchscientific research and analysis in the field of pharmaceuticals and biomedicine; pharmaceuticalbiomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparationsclinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticalsbiomedicineclinical trials and post-market trials

Class 44

Providing health and medical information; providing information relating to the diagnosticprophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseasesdisorders and conditions

Publications

History of USPTO decisions and trademark events.

16 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/25/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/25/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/10/2019

PUBO

PUBLISHED FOR OPPOSITION

12/10/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/20/2019

ALIE

ASSIGNED TO LIE

11/01/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/28/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/08/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/07/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/07/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/31/2019

GNRT

NON-FINAL ACTION E-MAILED

05/31/2019

CNRT

NON-FINAL ACTION WRITTEN

05/31/2019

DOCK

ASSIGNED TO EXAMINER

05/23/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/02/2019

NWAP

NEW APPLICATION ENTERED

03/18/2019

Continuous trademark protection

Get notified about every new filing that threatens AAA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.